Targeting autoimmune diabetes with gene therapy

Diabetes

Volumn 48, Issue 11, 1999, Pages 2107-2121

  Giannoukakis, Nick ^a   Rudert, William A ^a   Robbins, Paul D ^a   Trucco, Massimo ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

AUTOIMMUNE DISEASE; CARDIOVASCULAR DISEASE; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; GENE TARGETING; GENE THERAPY; HIGH RISK PATIENT; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVIEW;

ANIMALS; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; ISLETS OF LANGERHANS; TRANSPLANTATION, HETEROLOGOUS;

EID: 0032738310     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.11.2107     Document Type: Review

References (192)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus: the Diabetes Control and Complications Trial Research Group. N Engl J Med 329:977-986, 1993
2. Robbins PD, Tahara H, Ghivizzani SC: Viral vectors for gene therapy. Trends Biotechnol 16:35-40, 1998
3. Crystal RG: Transfer of genes to humans: early lessons and obstacles to success. Science 270:404-410, 1995
4. Mulligan RC: The basic science of gene therapy. Science 260:926-932, 1993
5. Csete ME, Benhamou PY, Drazan KE, Wu L, McIntee DF, Afra R, Mullen Y, Busuttil RW, Shaked A: Efficient gene transfer to pancreatic islets mediated by adenoviral vectors. Transplantation 59:263-268, 1995
6. Weber M, Deng S, Kucher T, Shaked A, Ketchum RJ, Brayman KL: Adenoviral transfection of isolated pancreatic islets: a study of programmed cell death (apoptosis) and islet function. J Surg Res 69:23-32, 1997
7. Muruve DA, Manfro RC, Strom TB, Libermann TA: Ex vivo adenovirus-mediated gene delivery leads to long-term expression in pancreatic islet transplants. Transplantation 64:542-546, 1997
8. Kochanek S, Clemens PR, Mitani K, Chen HH, Chan S, Caskey CT: A new adenoviral vector: replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase.Proc Natl Acad Sci U S A 93:5731-5736, 1996
9. Clemens PR, Kochanek S, Sunada Y, Chan S, Chen HH, Campbell KP, Caskey CT: In vivo muscle gene transfer of full-length dystrophin with an adenoviral vector that lacks all viral genes. Gene Ther 3:965-972, 1996
10. Schiedner G, Morral N, Parks RJ, Wu Y, Koopmans SC, Langston C, Graham FL, Beaudet AL, Kochanek S: Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nat Genet 18:180-183, 1998
11. Rabinovitch A, Suarez-Pinzon W, Strynadka K, Ju Q, Edelstein D, Brownlee M, Korbutt GS, Rajotte RV: Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects β-cells from cytokine-induced destruction. Diabetes 48:1223-1229, 1999
12. Liu Y, Rabinovitch A, Suarez-Pinzon W, Muhkerjee B, Brownlee M, Edelstein D, Federoff HJ: Expression of the bcl-2 gene from a defective HSV-1 amplicon vector protects pancreatic beta-cells from apoptosis. Hum Gene Ther 7:1719-1726, 1996
13. Glorioso JC, Goins WF, Schmidt MC, Oligino T, Krisky DM, Marconi PC, Cavalcoli JD, Ramakrishnan R, Poliani PL, Fink DJ: Engineering herpes simplex virus vectors for human gene therapy. Adv Pharmacol 40:103-136, 1997
14. Marconi P, Krisky D, Oligino T, Poliani PL, Ramakrishnan R, Goins WF, Fink DJ, Glorioso JC: Replication-defective herpes simplex virus vectors for gene transfer in vivo. Proc Natl Acad Sci U S A 93:11319-11320, 1996
15. Goins WF, Lee KA, Cavalcoli JD, O'Malley ME, DeKosky ST, Fink DJ, Glorioso JC: Herpes simplex virus type 1 vector-mediated expression of nerve growth factor protects dorsal root ganglion neurons from peroxide toxicity. J Virol 73:519-532, 1999
16. Naldini L, Blomer U, Gage FH, Trono D, Verma IM: Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci U S A 93:11382-11388, 1996
17. Zufferey R, Nagy D, Mandel RJ, Naldini L, Trono D: Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol 15:871-875, 1997
18. Kafri T, Blomer U, Peterson DA, Gage FH, Verma IM: Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat Genet 17:314-317, 1997
19. Gallichan WS, Kafri T, Krahl T, Verma IM, Sarvetnick N: Lentivirus-mediated transduction of islet grafts with interleukin 4 results in sustained gene expression and protection from insulitis. Hum Gene Ther 9:2717-2726, 1998
20. Giannoukakis N, Mi Z, Gambotto A, Eramo A, Ricordi C, Trucco M, Robbins PD: Infection of intact human islets by a lentiviral vector. Gene Ther 6:1545-1551, 1999
21. Ju Q, Edelstein D, Brendel MD, Brandhorst D, Brandhorst H, Bretzel RG, Brownlee M: Transduction of non-dividing adult human pancreatic beta cells by an integrating lentiviral vector. Diabetologia 41:736-739, 1998
22. Leibowitz G, Beattie GM, Kafri T, Cirulli V, Lopez AD, Hayek A, Levine F: Gene transfer to human pancreatic endocrine cells using viral vectors. Diabetes 48:745-753, 1999
23. Olsen JC: Gene transfer vectors derived from equine infectious anemia virus. Gene Ther 5:1481-1487, 1998
24. Poeschla EM, Wong-Staal F, Looney DJ: Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors. Nat Med 4:354-357, 1998
25. Xiao W, Chirmule N, Berta SC, McCullough B, Gao G, Wilson JM: Gene therapy vectors based on adeno-associated virus type 1. J Virol 73:3994-4003, 1999
26. Song S, Morgan M, Ellis T, Poirier A, Chesnut K, Wang J, Brantly M, Muzyczka N, Byrne BJ, Atkinson M, Flotte TR: Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors. Proc Natl Acad Sci U S A 95:14384-14388, 1998
27. Li J, Dressman D, Tsao YP, Sakamoto A, Hoffman EP, Xiao X: rAAV vector-mediated sarcoglycan gene transfer in a hamster model for limb girdle muscular dystrophy. Gene Ther 6:74-82, 1999
28. Wu P, Phillips MI, Bui J, Terwilliger EF: Adeno-associated virus vector-mediated transgene integration into neurons and other nondividing cell targets. J Virol 72:5919-5926, 1998
29. Kaplitt MG, Leone P, Samulski RJ, Xiao X, Pfaff DW, O'Malley KL, During MJ: Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet 8:148-154, 1994
30. Guo Z, Mital D, Mo YY, Tian Y, Shen J, Chong AS, Foster P, Sankary H, McChesney L, Jensik SC, Williams JW: Effect of gene gun-mediated CTLA4Ig and Fas ligand gene transfection on concordant xenogeneic islet graft rejection. Transplant Proc 30:589, 1998
31. Gainer AL, Korbutt GS, Rajotte RV, Warnock GL, Elliott JF: Expression of CTLA4-Ig by bioballistically transfected mouse islets promotes islet allograft survival. Transplantation 63:1017-1021, 1997
32. Gainer AL, Suarez-Pinzon WL, Min WP, Swiston JR, Hancock-Friesen C, Korbutt GS, Rajotte RV, Warnock GL, Elliott JF: Improved survival of bioballistically transfected mouse islet allografts expressing CTLA4-Ig or soluble Fas ligand. Transplantation 66:194-199, 1998
33. Gainer AL, Korbutt GS, Rajotte RV, Warnock GL, Elliott JF: Successful bioballistic transformation of mouse pancreatic islets while preserving cellular function. Transplantation 61:1567-1571, 1996
34. Welsh N, Oberg C, Hellerstrom C, Welsh M: Liposome mediated in vitro transfection of pancreatic islet cells. Biomed Biochim Acta 49:1157-1164, 1990
35. Rossini AA, Greiner DL, Mordes JP: Induction of immunologic tolerance for transplantation. Physiol Rev 79:99-141, 1999
36. French MB, Allison J, Cram DS, Thomas HE, Dempsey-Collier M, Silva A, Georgiou HM, Kay TW, Harrison LC, Lew AM: Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice. Diabetes 46:34-39, 1997
37. Posselt AM, Naji A, Roark JH, Markmann JF, Barker CF: Intrathymic islet transplantation in the spontaneously diabetic BB rat. Ann Surg 214:363-373, 1991
38. Posselt AM, Barker CF, Friedman AL, Naji A: Prevention of autoimmune diabetes in the BB rat by intrathymic islet transplantation at birth. Science 256:1321-1324, 1992
39. Posselt AM, Barker CF, Markmann JF, Roark JH, Naji A: Successful islet transplantation in the thymus of spontaneously diabetic BB rats. Transplant Proc 24:1023-1024, 1992
40. Koevary SB, Blomberg M: Prevention of diabetes in BB/Wor rats by intrathymic islet injection. J Clin Invest 89:512-516, 1992
41. Charlton B, Taylor-Edwards C, Tisch R, Fathman CG: Prevention of diabetes and insulitis by neonatal intrathymic islet administration in NOD mice. J Autoimmun 7:549-560, 1994
42. Cetkovic-Cvrlje M, Gerling IC, Muir A, Atkinson MA, Elliot JF, Leiter EH: Retardation or acceleration of diabetes in NOD/Lt mice mediated by intrathymic administration of candidate β-cell antigens. Diabetes 46:1975-1982, 1997
43. Posselt AM, Odorico JS, Barker CF, Naji A: Promotion of pancreatic islet allograft survival by intrathymic transplantation of bone marrow. Diabetes 41:771-775, 1992
44. Oluwole SF, Jin MX, Chowdhury NC, Ohajekwe OA: Effectiveness of intrathymic inoculation of soluble antigens in the induction of specific unresponsiveness to rat islet allografts without transient recipient immunosuppression. Transplantation 58:1077-1081, 1994
45. Singer SM, Tisch R, Yang XD, Sytwu HK, Liblau R, McDevitt HO: Prevention of diabetes in NOD mice by a mutated I-Ab transgene. Diabetes 47:1570-1577, 1998
46. DeMatteo RP, Raper SE, Ahn M, Fisher KJ, Burke C, Radu A, Widera G, Claytor BR, Barker CF, Markmann JF: Gene transfer to the thymus: a means of abrogating the immune response to recombinant adenovirus. Ann Surg 222:229-242, 1995
47. Remuzzi G, Ferrazzi P, Bontempelli M, Senni M, Glauber M, Ruggenenti P, Perico N: Preliminary results of intrathymic injection of donor cells to prevent acute rejection in human heart transplantation. J Am Soc Nephrol 6:1291-1294, 1995.
48. Lacy PE, Finke EH: Activation of intraislet lymphoid cells causes destruction of islet cells. Am J Pathol 138:1183-1190, 1991
49. Lacy PE: The intraislet macrophage and type 1 diabetes. Mt Sinai J Med 61:170-174, 1994
50. Corbett JA, McDaniel ML: Intraislet release of interleukin 1 inhibits beta cell function by inducing beta cell expression of inducible nitric oxide synthase. J Exp Med 181:559-568, 1995
51. Arnush M, Scarim AL, Heitmeier MR, Kelly CB, Corbett JA: Potential role of resident islet macrophage activation in the initiation of autoimmune diabetes. J Immunol 160:2684-2691, 1998
52. Arnush M, Heitmeier MR, Scarim AL, Marino MH, Manning PT, Corbett JA: IL-1 produced and released endogenously within human islets inhibits beta cell function. J Clin Invest 102:516-526, 1998
53. McDaniel ML, Kwon G, Hill JR, Marshall CA, Corbett JA: Cytokines and nitric oxide in islet inflammation and diabetes. Proc Soc Exp Biol Med 211:24-32, 1996
54. Stassi G, Maria RD, Trucco G, Rudert W, Testi R, Galluzzo A, Giordano C, Trucco M: Nitric oxide primes pancreatic beta cells for Fas-mediated destruction in insulin-dependent diabetes mellitus. J Exp Med 186: 1193-1200, 1997
55. Corbett JA, Wang JL, Misko TP, Zhao W, Hickey WF, McDaniel ML: Nitric oxide mediates IL-1 beta-induced islet dysfunction and destruction: prevention by dexamethasone. Autoimmunity 15:145-153, 1993
56. Corbett JA, Wang JL, Sweetland MA, Lancaster JR Jr, McDaniel ML: Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans: evidence for the beta-cell as a source and site of action of nitric oxide. J Clin Invest 90:2384-2391, 1992
57. Giannoukakis N, Rudert WA, Ghivizzani S, Ricordi C, Trucco M, Robbins PD: Adenoviral gene transfer of the interleukin-1 receptor antagonist protein to human islets prevents IL-1-beta-induced dysfunction and apoptosis activation in vitro. Diabetes 48:1730-1736, 1999
58. Hunger RE, Camaud C, Garcia I, Vassalli P, Mueller C: Prevention of autoimmune diabetes mellitus in NOD mice by transgenic expression of soluble tumor necrosis factor receptor p55. Eur J Immunol 27:255-261, 1997
59. Hunger RE, Muller S, Laissue JA, Hess MW, Carnaud C, Garcia I, Mueller C: Inhibition of submandibular and lacrimal gland infiltration in nonobese diabetic mice by transgenic expression of soluble TNF-receptor p55. J Clin Invest 98:954-961, 1996
60. Le CH, Nicolson AG, Morales A, Sewell KL: Suppression of collagen-induced arthritis through adenovirus-mediated transfer of a modified tumor necrosis factor alpha receptor gene. Arthritis Rheum 40:1662-1669, 1997
61. Ghivizzani SC, Lechman ER, Kang R, Tio C, Kolls J, Evans CH, Robbins PD: Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects. Proc Natl Acad Sci U S A 95:4613-4618, 1998
62. Baldwin AS Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 14:649-683, 1996
63. Miagkov AV, Kovalenko DV, Brown CE, Didsbury JR, Cogswell JP, Stimpson SA, Baldwin AS, Makarov SS: NF-kappa B activation provides the potential link between inflammation and hyperplasia in the arthritic joint. Proc Natl Acad Sci U S A 95:13859-13864, 1998
64. Makarov SS, Johnston WN, Olsen JC, Watson JM, Mondal K, Rinehart C, Haskill JS: NF-kappa B as a target for anti-inflammatory gene therapy: suppression of inflammatory responses in monocytic and stromal cells by stable gene transfer of I kappa B alpha cDNA. Gene Ther 4:846-852, 1997
65. Lieber A, He CY, Meuse L, Himeda C, Wilson C, Kay MA: Inhibition of NF-kappa B activation in combination with bcl-2 expression allows for persistence of first-generation adenovirus vectors in the mouse liver. J Virol 72:9267-9277, 1998
66. Foxwell B, Browne K, Bondeson J, Clarke C, de Martin R, Brennan F, Feldmann M: Efficient adenoviral infection with I kappa B alpha reveals that macrophage tumor necrosis factor alpha production in rheumatoid arthritis is NF-kappa B dependent. Proc Natl Acad Sci U S A 95:8211-8215, 1998
67. Bondeson J, Browne KA, Brennan FM, Foxwell BM, Feldmann M: Selective regulation of cytokine induction by adenoviral gene transfer of I kappa B alpha into human macrophages: lipopolysaccharide-induced, but not zymosan-induced, proinflammatory cytokines are inhibited, but IL-10 is nuclear factor-kappa B independent. J Immunol 162:2939-2945, 1999
68. Jobin C, Panja A, Hellerbrand C, Iimuro Y, Didonato J, Brenner DA, Sartor RB: Inhibition of proinflammatory molecule production by adenovirus-mediated expression of a nuclear factor kappa B super-repressor in human intestinal epithelial cells. J Immunol 160:410-418, 1998
69. Jobin C, Hellerbrand C, Licato LL, Brenner DA, Sartor RB: Mediation by NF-kappa B of cytokine induced expression of intercellular adhesion molecule 1 (ICAM-1) in an intestinal epithelial cell line, a process blocked by proteasome inhibitors. Gut 42:779-787, 1998
70. Thomson AW, Lu L, Murase N, Demetris AJ, Rao AS, Starzl TE: Microchimerism, dendritic cell progenitors and transplantation tolerance. Stem Cells 13:622-639, 1995
71. Lenschow DJ, Zeng Y, Thistlethwaite JR, Montag A, Brady W, Gibson MG, Linsley PS, Bluestone JA: Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science 257:789-792, 1992
72. Steurer W, Nickerson PW, Steele AW, Steiger J, Zheng XX, Strom TB: Ex vivo coating of islet cell allografts with murine CTLA4/Fc promotes graft tolerance. J Immunol 155:1165-1174, 1995
73. Weber CJ, Hagler MK, Chryssochoos JT, Larsen CP, Pearson TC, Jensen P, Kapp JA, Linsley PS: CTLA4-Ig prolongs survival of microencapsulated rabbit islet xenografts in spontaneously diabetic Nod mice. Transplant Proc 28:821-823, 1996
74. Weber CJ, Hagler MK, Chryssochoos JT, Kapp JA, Korbutt GS, Rajotte RV, Linsley PS: CTLA4-Ig prolongs survival of microencapsulated neonatal porcine islet xenografts in diabetic NOD mice. Cell Transplant 6:505-508, 1997
75. Levisetti MG, Padrid PA, Szot GL, Mittal N, Meehan SM, Wardrip CL, Gray GS, Bruce DS, Thistlethwaite JR Jr, Bluestone JA: Immunosuppressive effects of human CTLA4Ig in a non-human primate model of allogeneic pancreatic islet transplantation. J Immunol 159:5187-5191, 1997
76. Chahine AA, Yu M, McKernan MM, Stoeckert C, Lau HT: Immunomodulation of pancreatic islet allografts in mice with CTLA4Ig secreting muscle cells. Transplantation 59:1313-1318, 1995
77. Smith DK, Korbutt GS, Suarez-Pinzon WL, Kao D, Rajotte RV, Elliott JF: Interleukin-4 or interleukin-10 expressed from adenovirus-transduced syngeneic islet grafts fails to prevent beta cell destruction in diabetic NOD mice. Transplantation 64:1040-1049, 1997
78. Gallichan WS, Balasa B, Davies JD, Sarvetnick N: Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse. J Immunol 163:1696-1703, 1999
79. Davies JD, Mueller R, Minson S, O'Connor E, Krahl T, Sarvetnick N: Interleukin-4 secretion by the allograft fails to affect the allograft-specific interleukin-4 response in vitro. Transplantation 67:1583-1589, 1999
80. Tripp CS, Wolf SF, Unanue ER: Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc Natl Acad Sci U S A 90:3725-3729, 1993
81. Chen WF, Zlotnik A: IL-10: a novel cytotoxic T cell differentiation factor. J Immunol 147:528-534, 1991
82. MacNeil IA, Suda T, Moore KW, Mosmann TR, Zlotnik A: IL-10, a novel growth cofactor for mature and immature T cells. J Immunol 145: 4167-4173, 1990
83. Qin L, Ding Y, Pahud DR, Robson ND, Shaked A, Bromberg JS: Adenovirus-mediated gene transfer of viral interleukin-10 inhibits the immune response to both alloantigen and adenoviral antigen. Hum Gene Ther 8:1365-1374, 1997
84. Bromberg JS, Debruyne LA, Qin L: Interactions between the immune system and gene therapy vectors: bidirectional regulation of response and expression. Adv Immunol 69:353-409, 1998
85. Benhamou PY, Mullen Y, Shaked A, Bahmiller D, Csete ME: Decreased alloreactivity to human islets secreting recombinant viral interleukin 10. Transplantation 62:1306-1312, 1996
86. Balasa B, Sarvetnick N: The paradoxical effects of interleukin 10 in the immunoregulation of autoimmune diabetes. J Autoimmun 9:283-286, 1996
87. Lee MS, Wogensen L, Shizuru J, Oldstone MB, Sarvetnick N: Pancreatic islet production of murine interleukin-10 does not inhibit immune-mediated tissue destruction. J Clin Invest 93:1332-1338, 1994
88. Nitta Y, Tashiro F, Tokui M, Shimada A, Takei I, Tabayashi K, Miyazaki J: Systemic delivery of interleukin 10 by intramuscular injection of expression plasmid DNA prevents autoimmune diabetes in nonobese diabetic mice. Hum Gene Ther 9:1701-1707, 1998
89. Gray JD, Hirokawa M, Horwitz DA: The role of transforming growth factor beta in the generation of suppression: an interaction between CD8+ T and NK cells. J Exp Med 180:1937-1942, 1994
90. Deng S, Ketchum RJ, Yang ZD, Kucher T, Weber M, Shaked A, Naji A, Brayman KL: IL-10 and TGF-beta gene transfer to rodent islets: effect on xenogeneic islet graft survival in naive and B-cell-deficient mice. Transplant Proc 29:2207-2208, 1997
91. Deng S, Yang ZD, Ketchum RJ, Kucher T, Weber M, Shaked A, Naji A, Brayman KL: Transfer of genes for IL-10 and TGF-beta to isolated human pancreatic islets. Transplant Proc 29:2206, 1997
92. Deng S, Ketchum RJ, Kucher T, Weber M, Shaked A, Naji A, Brayman KL: IL-10 and TGF-beta gene transfer for xenogeneic islet transplantation: comparison of effect in concordant vs discordant combination. Transplant Proc 29:2204-2205, 1997
93. Lee MS, Sawyer S, Arnush M, Krahl T, von Herrath M, Oldstone MA, Sarvetnick N: Transforming growth factor-beta fails to inhibit allograft rejection or virus-induced autoimmune diabetes in transgenic mice. Transplantation 61:1112-1115, 1996
94. Piccirillo CA, Chang Y, Prud'homme GJ: TGF-betal somatic gene therapy prevents autoimmune disease in nonobese diabetic mice. J Immunol 161:3950-3956, 1998
95. Utsugi T, Nagata M, Kawamura T, Yoon JW: Prevention of recurrent diabetes in syngeneic islet-transplanted NOD mice by transfusion of autoreactive T lymphocytes. Transplantation 57:1799-1804, 1994
96. Han HS, Jun HS, Utsugi T, Yoon JW: A new type of CD4+ suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice. J Autoimmun 9:331-339, 1996
97. Moritani M, Yoshimoto K, Ii S, Kondo M, Iwahana H, Yamaoka T, Sano T, Nakano N, Kikutani H, Itakura M: Prevention of adoptively transferred diabetes in nonobese diabetic mice with IL-10-transduced islet-specific Th1 lymphocytes: a gene therapy model for autoimmune diabetes. J Clin Invest 98:1851-1859, 1996
98. Yasuda H, Nagata M, Arisawa K, Yoshida R, Fugihira K, Okamoto N, Moriyama H, Mikki M, Saito I, Hamada H, Yokono K, Kasuga M: Local expression of immunoregulatory IL-12p40 gene prolonged syngeneic islet graft survival in diabetic NOD mice. J Clin Invest 102:1807-1814, 1998
99. Steptoe RJ, Thomson AW: Dendritic cells and tolerance induction. Clin Exp Immunol 105:397-402, 1996
100. Tafuri A, Bowers WE, Handler ES, Appel M, Lew R, Greiner D, Mordes JP, Rossini AA: High stimulatory activity of dendritic cells from diabetes-prone BioBreeding/Worcester rats exposed to macrophage-derived factors. J Clin Invest 91:2040-2048, 1993
101. Dahlen E, Dawe K, Ohlsson L, Hedlund G: Dendritic cells and macrophages are the first and major producers of TNF-alpha in pancreatic islets in the nonobese diabetic mouse. J Immunol 160:3585-3593, 1998
102. Lo D, Reilly CR, Scott B, Liblau R, McDevitt HO, Burkly LC: Antigen-presenting cells in adoptively transferred and spontaneous autoimmune diabetes. Eur J Immunol 23:1693-1698, 1993
103. Moriyama H, Yokono K, Amano K, Nagata M, Hasegawa Y, Okamoto N, Tsukamoto K, Mild M, Yoneda R, Yagi N, Tominaga Y, Kikutani H, Hioki K, Okumura K, Yagita H, Kasuga M: Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway. J Immunol 157:3737-3743, 1996
104. Martin S, Heidenthal E, Schulte B, Rothe H, Kolb H: Soluble forms of intercellular adhesion molecule-1 inhibit insulitis and onset of autoimmune diabetes. Diabetologia 41:1298-1303, 1998
105. Hasegawa Y, Yokono K, Taki T, Amano K, Tominaga Y, Yoneda R, Yagi N, Maeda S, Yagita H, Okumura K, Kasuga M: Prevention of autoimmune insulin-dependent diabetes in non-obese diabetic mice by anti-LFA-1 and anti-ICAM-1 mAb. Int Immunol 6:831-838, 1994
106. Takayama T, Nishioka Y, Lu L, Lotze MT, Tahara H, Thomson AW: Retroviral delivery of viral interleukin-10 into myeloid dendritic cells markedly inhibits their allostimulatory activity and promotes the induction of T-cell hyporesponsiveness. Transplantation 66:1567-1574, 1998
107. Lu L, Lee WC, Gambotto A, Zhong C, Robbins PD, Qian S, Fung JJ, Thomson AW: Transduction of dendritic cells with adenoviral vectors encoding CTLA4-Ig markedly reduces their allostimulatory activity. Transplant Proc 31:797-801, 1999
108. Lee WC, Zhong C, Qian S, Wan Y, Gauldie J, Mi Z, Robbins PD, Thomson AW, Lu L: Phenotype, function, and in vivo migration and survival of allogeneic dendritic cell progenitors genetically engineered to express TGF-beta. Transplantation 66:1810-1817, 1998
109. Kenyon NS, Fernandez LA, Lehmann R, Masetti M, Ranuncoli A, Chatzipetrou M, Iaria G, Han D, Wagner JL, Ruiz P, Berho M, Inverardi L, Alejandro R, Mintz DH, Kirk AD, Harlan DM, Burkly LC, Ricordi C: Long-term survival and function of intrahepatic islet allograft in baboons treated with humanized anti-CD154. Diabetes 48:1473-1481, 1999
110. Kenyon NS, Chatzipetrou M, Masetti M, Ranuncoli A, Oliveira M, Wagner JL, Kirk AD, Harlan DM, Burkly LC, Ricordi C: Long-term survival and function of intrahepatic islet allografis in rhesus monkeys treated with humanized anti-CD154. Proc Natl Acad Sci U S A 96:8132-8137, 1999
111. Eggert AA, Schreurs MW, Boerman OC, Oyen WJ, deBoer Aj, Punt CJ, Figdor CG, Adema GJ: Biodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration. Cancer Res 59: 3340-3345, 1999
112. Nagata S, Suda T: Fas and Fas ligand: lpr and gld mutations. Immunol Today 16:39-43, 1995
113. Nagata S, Golstein P: The Fas death factor. Science 267:1449-1456, 1995
114. Nagata S: Apoptosis mediated by the Fas system. Prog Mol Subcell Biol 16:87-103, 1996
115. Kabelitz D: Apoptosis, graft rejection, and transplantation tolerance. Transplantatian 65:869-875, 1998
116. Stuart PM, Griffith TS, Usui N, Pepose J, Yu X, Ferguson TA: CD95 ligand (FasL)-induced apoptosis is necessary for comeal allograft survival. J Clin Invest 99:396-402, 1997
117. Lau HT, Yu M, Fontana A, Stoeckert CJ Jr: Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science 273:109-112, 1996
118. Kang SM, Schneider DB, Lin Z, Hanahan D, Dichek DA, Stock PG, Baekkeskov S: Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction. Nat Med 3:738-743, 1997
119. Fandrich F, Lin X, Zhu X, Kloppel G, Parwaresch R, Kremer B: CD95L confers immune privilege to liver grafts which are spontaneously accepted. Transplant Proc 30:1057-1058, 1998
120. Swenson KM, Ke B, Wang T, Markowitz JS, Maggard MA, Spear GS, Imagawa DK, Goss JA, Busuttil RW, Seu P: Fas ligand gene transfer to renal allografts in rats: effects on allograft survival. Transplantation 65:155-160, 1998
121. Suda T, Hashimoto H, Tanaka M, Ochi T, Nagata S: Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing. J Exp Med 186:2045-2050, 1997
122. Miwa K, Asano M, Horai R, Iwakura Y, Nagata S, Suda T: Caspase 1-independent IL-1-beta release and inflammation induced by the apoptosis inducer Fas ligand. Nat Med 4:1287-1292, 1998
123. Kawahara A, Kobayashi T, Nagata S: Inhibition of Fas-induced apoptosis by Bcl-2. Oncogene 17:2549-2554, 1998
124. De Valck D, Jin DY, Heyninck K, Van de Craen M, Contreras R, Fiers W, Jeang KT, Beyaert R: The zinc finger protein A20 interacts with a novel anti-apoptotic protein which is cleaved by specific caspases. Oncogene 18:4182-4190, 1999
125. Grey ST, Arvelo MB, Hasenkamp WM, Bach FH, Ferran C: Adenovirus-mediated gene transfer of the anti-apoptotic protein A20 in rodent islets inhibits IL-1 beta-induced NO release. Transplant Proc 31:789, 1999
126. Ashkenazi A, Dixit VM: Apoptosis control by death and decoy receptors. Curr Opin Cell Biol 11:255-260, 1999
127. Schneider P, Thome M, Burns K, Bodmer JL, Hofmann K, Kataoka T, Holler N, Tschopp J: TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB. Immunity 7:831-836, 1997
128. Kayagaki N, Yamaguchi N, Nakayam M, Takeda K, Akiba H, Tsutsui H, Okamura H, Nakanishi K, Okumura K, Yagita H: Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells. J Immunol 163:1906-1913, 1999
129. Mariani SM, Krammer PH: Surface expression of TRAIL/Apo-2 ligand in activated mouse T and B cells. Eur J Immunol 28:1492-1498, 1998
130. Wajant H, Johannes FJ, Haas E, Siemienski K, Schwenzer R, Schubert G, Weiss T, Grell M, Scheurich P: Dominant-negative FADD inhibits TNFR60-, Fas/Apo1-and TRAIL-R/Apo2-mediated cell death but not gene induction. Curr Biol 8:113-116, 1998
131. Hu S, Vincenz C, Ni J, Gentz R, Dixit VM: I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1-and CD-95-induced apoptosis. J Biol Chem 272:17255-17257, 1997
132. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, Bodmer JL, Schroter M, Burns K, Mattmann C, Rimoldi D, French LE, Tschopp J: Inhibition of death receptor signals by cellular FLIP. Nature 388:190-195, 1997
133. Thome M, Schneider P, Hofmann K, Fickenscher H, Meinl E, Neipel F, Mattmann C, Burns K, Bodmer JL, Schroter M, Scaffidi C, Klammer PH, Peter ME, Tschopp J: Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386:517-521, 1997
134. Jaattela M, Wissing D: Heat-shock proteins protect cells from monocyte cytotoxicity: possible mechanism of self-protection. J Exp Med 177:231-236, 1993
135. Ricordi C, Tzakis AG, Carroll PB, Zeng YJ, Rilo HL, Alejandro R, Shapiro A, Fung JJ, Demetris AJ, Mintz DH, Starzl TE: Human islet isolation and allotransplantation in 22 consecutive cases. Transplantation 53:407-414, 1992
136. Robertson GS, Dennison AR, Johnson PR, London NJ: A review of pancreatic autotransplantation. Hepatogastroenterology 45:226-235, 1998
137. Benhamou PY, Moriscot C, Richard MJ, Kerr-Conte J, Pattou F, Chroboczek J, Lemarchand P, Halimi S: Adenoviral-mediated catalase gene transfer protects porcine and human islets in vitro against oxidative stress. Transplant Proc 30:459, 1998
138. Hohmeier HE, Thigpen A, Tran VV, Davis R, Newgard CB: Stable expression of manganese superoxide dismutase (MnSOD) in insulinoma cells prevents IL-1-beta-induced cytotoxicity and reduces nitric oxide production. J Clin Invest 101:1811-1820, 1998
139. Zwacka RM, Zhou W, Zhang Y, Darby CJ, Dudus L, Halldorson J, Oberley L, Engelhardt JF: Redox gene therapy for ischemia/reperfusion injury of the liver reduces AP1 and NF-kappa B activation. Nat Med 4:698-704, 1998
140. Tiedge M, Lortz S, Munday R, Lenzen S: Protection against the co-operative toxicity of nitric oxide and oxygen free radicals by overexpression of antioxidant enzymes in bioengineered insulin-producing RINm5F cells. Diabetologia 42:849-855, 1999
141. Munn DH, Zhou M, Attwood JT, Bondarev I, Conway SJ, Marshall B, Brown C, Mellor AL: Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281:1191-1193, 1998
142. Munn DH, Shafizadeh E, Attwood JT, Bondarev I, Pashine A, Mellor AL: Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med 189:1363-1372, 1999
143. Tafuri A, Alferink J, Möller P, Hämmerling GJ, Arnold B: T cell awareness of paternal alloantigens during pregnancy. Science 270:630-633, 1995
144. Kumagai-Braesch M, Satake M, Qian Y, Holgersson J, Moller E: Human NK cell and ADCC reactivity against xenogeneic porcine target cells including fetal porcine islet cells. Xenotransplantation 5:132-145, 1998
145. Karlsson-Parra A, Ridderstad A, Wallgren AC, Moller E, Ljunggren HG, Korsgren O: Xenograft rejection of porcine islet-like cell clusters in normal and natural killer cell-depleted mice. Transplantation 61:1313-1320, 1996
146. Markmann JF, Posselt AM, Bassiri H, Brayman KL, Woehrle M, Hickey WF, Silvers WK, Barker CF, Naji A: Major-histocompatibility-complex restricted and nonrestricted autoimmune effector mechanisms in BB rats. Transplantation 52:662-667, 1991
147. Nakamura N, Woda BA, Tafuri A, Greiner DL, Reynolds CW, Ortaldo J, Chick W, Handler ES, Mordes JP, Rossini AA: Intrinsic cytotoxicity of natural killer cells to pancreatic islets in vitro. Diabetes 39:836-843, 1990
148. Like AA, Biron CA, Weringer EJ, Byman K, Sroczynski E, Guberski DL: Prevention of diabetes in BioBreeding/Worcester rats with monoclonal antibodies that recognize T lymphocytes or natural killer cells. J Exp Med 164:1145-1159, 1986
149. MakKay P, Jacobson J, Rabinovitch A: Spontaneous diabetes mellitus in the Bio-Breeding/Worcester rat: evidence in vitro for natural killer cell lysis of islet cells. J Clin Invest 77:916-924, 1986
150. Pazmany L, Mandelboim O, Vales-Gomez M, Davis DM, Reyburn HT, Strominger JL: Protection from natural killer cell-mediated lysis by HLA-G expression on target cells. Science 274:792-795, 1996
151. Soderstrom K, Corliss B, Lanier LL, Phillips JH: CD94/NKG2 is the predominant inhibitory receptor involved in recognition of HLA-G by decidual and peripheral blood NK cells. J Immunol 159:1072-1075, 1997
152. Sasaki H, Xu XC, Smith DM, Howard T, Mohanakumar T: HLA-G expression products porcine endothelial cells against natural killer cell-mediated xenogeneic cytotoxicity. Transplantation 67:31-37, 1999
153. Le Gal FA, Riteau B, Sedlik C, Khalil-Daher I, Menier C, Dausset J, Guillet JG, Carosella ED, Rouas-Freiss N: HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes. Int Immunol 11:1351-1356, 1999
154. Bradley LM, Asensio VC, Schioetz LK, Harbertson J, Krahl T, Patstone G, Woolf N, Campbell IL, Sarvetnick N: Islet-specific Th1, but not Th2, cells secrete multiple chemokines and promote rapid induction of autoimmune diabetes. J Immunol 162:2511-2520, 1999
155. Grewal IS, Rutledge BJ, Fiorillo JA, Gu L, Gladue RP, Flavell RA, Rollins BJ: Transgenic monocyte chemoattractant protein-1 (MCP-1) in pancreatic islets produces monocyte-rich insulitis without diabetes: abrogation by a second transgene expressing sytemic MCP-1. J Immunol 159:401-408, 1997
156. Walzog B, Scharffetter-Kochanek K, Gaehtgens P: Impairment of neutrophil emigration in CD18-null mice. Am J Physiol 276:G1125-G1130, 1999
157. Yagi N, Yokono K, Amano K, Nagata M, Tsukamoto K, Hasegawa Y, Yoneda R, Okamoto N, Noriyama H, Mild M, Tonunaga Y, Miyazaki J, Yagita H, Okumura K, Mizoguchi A, Miki A, Ide C, Maeda S, Kasuga M: Expression of intercellular adhesion molecule 1 on pancreatic beta-cells accelerates β-cell destruction by cytotoxic T-cells in murine autoimmune diabetes. Diabetes 44:744-752, 1995
158. Prieto J, Kaaya EE, Juntti-Berggren L, Berggren PO, Sandler S, Biberfeld P, Pataroyo M: Induction of intercellular adhesion molecule-1 (CD54) on isolated mouse pancreatic beta cells by inflammatory cytokines. Clin Immunol Immunopathol 65:247-253, 1992
159. Katz SM, Browne B, Phan T, Wang ME, Bennett CF, Stepkowski SM, Kahan BD: Efficacy of ICAM-1 antisense oligonucleotide in pancreatic islet transplantation. Transpl Proc 27:3214, 1995
160. Campbell IL, Cutri A, Wilkinson D, Boyd AW, Harrison LC: Intercellular adhesion molecule 1 is induced on isolated endocrine islet cells by cytokines but not by reovirus infection. Proc Natl Acad Sci U S A 86:4282-4286, 1989
161. Moriyama H, Yokono K, Amano K, Nagata M, Hasegawa Y, Okamoto N, Tsukamoto K, Miki M, Yoneda R, Yagi N, Tominaga Y, Kikutani H, Hioki K, Okumura K, Yagita H, Kasuga M: Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway. J Immunol 157:3737-3743, 1996
162. Yang XD, Michie SA, Mebius RE, Tisch R, Weissman I, McDevitt HO: The role of cell adhesion molecules in the development of IDDM: implications for pathogenesis and therapy. Diabetes 45:705-710, 1966
163. Ohta Y, Gotoh M, Ohzato H, Fukuzaki T, Nishihara M, Dono K, Umeshita K, Sakon M, Yagita H, Okumura K, Tanaka T, Kawashima H, Miyasaka M, Monden M: Direct antigen presentation through binding of donor intercellular adhesion molecule-1 to recipient lymphocyte function-associated antigen-1 molecules in xenograft rejection. Transplantation 65:1094-1100, 1998
164. Zeng Y, Gage A, Montag A, Rothlein R, Thistlethwaite JF, Bluestone JA: Inhibition of transplant rejection by pretreatment of xenogeneic pancreatic islet cells with anti-ICAM-1 antibodies. Transplantation 58:681-689, 1994
165. Herold KC, Vezys V, Gage A, Montag AG: Prevention of autoimmune diabetes by treatment with anti-LFA-1 and anti-ICAM-1 monoclonal antibodies. Cell Immunol 157:489-500, 1994
166. Hasegawa Y, Yokono K, Taki T, Amano K, Tominaga Y, Yoneda R, Yagi N, Maeda S, Yagita H, Okumura K, Kasuga M: Prevention of autoimmune insulin-dependent diabetes in non-obese diabetic mice by anti-LFA-1 and anti-ICAM-1 mAb. Int Immunol 6:831-838, 1994
167. Martin S, Heidenthal E, Schulte B, Rothe H, Kolb H: Soluble forms of intercellular adhesion molecule-1 inhibit insulitis and onset of autoimmune diabetes. Diabetologia 41:1298-1303, 1998
168. Jakubowski A, Ehrenfels BN, Pepinsky RB, Burkly LC: Vascular cell adhesion molecule-Ig fusion protein selectively targets activated alpha 4-integrin receptors in vivo: inhibition of autoimmune diabetes in an adoptive transfer model in nonobese diabetic mice. J Immunol 155:938-946, 1995
169. Fryer JP, Leventhal JR, Matas AJ: The emergence of xenotransplantation. Transpl Immunol 3:21-31, 1995
170. Weir GC, Bonner-Weir S: Scientific and political impediments to successful islet transplantation. Diabetes 46:1247-1256, 1997
171. Lin SS, Weidner BC, Byrne GW, Diamond LE, Lawson JH, Hoopes CW, Daniels LJ, Daggett CW, Parker W, Harland RC, Davis RD, Bollinger RR, Logan JS, Platt JL: The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants. J Clin Invest 101:1745-1756, 1998
172. Cotterell AH, Collins BH, Parker W, Harland RC, Platt JL: The humoral immune response in humans following cross-perfusion of porcine organs. Transplantation 60:861-868, 1995
173. Leventhal JR, John R, Fryer JR Wilson JC, Derlich JM, Remiszewski J, Dalmasso AP, Matas AJ, Bolman RM III: Removal of baboon and human antiporcine IgG and IgM natural antibodies by immunoadsorption: results of in vitro and in vivo studies. Transplantation 59:294-300, 1995
174. Sandrin MS, Vaughan HA, Dabkowski PL, McKenzie IF: Anti-pig IgM antibodies in human serum react predominantly with Gal(alpha 1-3)Gal epitopes. Proc Natl Acad Sci U S A 90:11391-11395, 1993
175. Sandrin MS, Osman N, McKenzie IF: Transgenic approaches for the reduction of Galalpha(1,3)Gal for xenotransplantation. Front Biosci 2:e1-e11, 1997
176. Mirenda V, Le Mauff B, Cassard A, Huvelin JM, Boeffard F, Faivre A, Soulillou JP, Angeon I: Intact pig pancreatic islet function in the presence of human xenoreactive natural antibody binding and complement activation. Transplantation 63:1452-1462, 1997
177. Galili U, Tibell A, Samuelsson B, Rydberg L, Groth CG: Increased anti-Gal activity in diabetic patients transplanted with fetal porcine islet cell clusters. Transplantation 59:1549-1556, 1995
178. McKenzie IF, Koulmanda M, Mandel TE, Sandrin MS: Pig islet xenografts are susceptible to "anti-pig" but not Gal alpha(1,3)Gal antibody plus complement in Gal o/o mice. J Immunol 161:5116-5119, 1998
179. Hamelmann W, Gray DW, Cairns TD, Ozasa T, Ferguson DJ, Cahill A, Welsh KI, Morris PJ: Immediate destruction of xenogeneic islets in a primate model. Transplantation 58:1109-1114, 1994
180. Mandel TE: Fetal islet xenotransplantation in rodents and primates. J Mol Med 77:155-160, 1999
181. Bracy JL, Sachs DH, Iacomini J: Inhibition of xenoreactive natural antibody production by retroviral gene therapy. Science 281:1845-1847, 1998
182. Takahashi T, Saadi S, Platt JL: Recent advances in the immunology of xenotransplantation. Immunol Res 16:273-297, 1997
183. Schmoeckel M, Bhatti FN, Zaidi A, Cozzi E, Waterworth PD, Tolan MJ, Goddard M, Warner RG, Langford GA, Dunning JJ, Wallwork J, White DJ: Orthotopic heart transplantation in a transgenic pig-to-primate model. Transplantation 65:1570-1577, 1998
184. Byrne GW, McCurry KR, Martin MJ, McClellan SM, Platt JL, Logan JS: Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage. Transplantation 63:149-155, 1997
185. Pruitt SK, Baldwin WMd, Marsh HC Jr, Lin SS, Yeh CG, Bollinger RR: The effect of soluble complement receptor type 1 on hyperacute xenograft rejection. Transplantation 52:868-873, 1991
186. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Siimonetti DW, Craig S, Marshak DR: Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147, 1999
187. Ferrari G, Cusella-DeAngelis G, Coletta M, Paolucci E, Stornaiuolo A, Cossu G, Mavilio F: Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279:1528-1530, 1998
188. Raper SE, DeMatteo RP: Adenovirus-mediated in vivo gene transfer and expression in normal rat pancreas. Pancreas 12:401-410, 1996
189. Kamel I, Mikhail Y, Beshir S: Study on the innervation of the pancreas of the rat. Acta Anat 104:237-241, 1979
190. Kirchgessner AL, Gershon MD: Innervation of the pancreas by neurons in the gut. J Neurosci 10:1626-1642, 1990
191. Smith PH, Davis BJ: Morphological and functional aspects of pancreatic islet innervation. J Auton Nerv Syst 9:53-66, 1983
192. Zhang HG, Liu D, Heike Y, Yang P, Wang Z, Wang X, Curiel DT, Zhou T, Mountz JD: Induction of specific T-cell tolerance by adenovirus-transfected, Fas ligand-producingantigen presenting cells. Nat Biotechnol 16:1045-1049, 1998